Luteolin-3′,7-diglucoside

• UNSPSC Description:

  Luteolin-3′,7-diglucoside is a glycoside that can be isolated from R. luteolin. Luteolin-3′,7-diglucoside significantly inhibits cataracts induced in ovine lenses. Luteolin-3′,7-diglucoside inhibits the activity of Ureaplasma urealyticumATCC and clinical strains[1][2][3].

• Target Antigen:

  Others

• Type:

  Natural Products

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/luteolin-3-7-diglucoside.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C(C(OC(C(C=C2)=CC(O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@H]3O)CO)=C2O)=C1)=CC(O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]([C@H]4O)CO)=C5)=C5O

• Molecular Weight:

  610.52

• References & Citations:

  [1]Cristea D, et al. Identification and quantitative HPLC analysis of the main flavonoids present in weld (Reseda luteola L.)[J]. Dyes and Pigments, 2003, 57(3): 267-272.|[2]Vit P, et al. Putative anticataract properties of honey studied by the action of flavonoids on a lens culture model[J]. Journal of Health Science, 2008, 54(2): 196-202.|[3]Bisignano C, et al. In Vitro Efficacy of Crataegus oxycantha L.(Hawthorn) and Its Major Components against ATCC and Clinical Strains of Ureaplasma urealyticum[J]. Advances in Microbiology, 2016, 6(12): 909-916.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  52187-80-1